Intriguingly, scRNA-seq analysis indicates that the expression of EP2 (PTGER2) and EP4 (PTGER4) is negatively correlated with patient prognosis in different tumor types (LUSC, BRCA, LIHC, and OV). This evidence concerns the gene PTGER2 and neoplasm.